Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New York Blood Health
New York City, New York, United States
- Ownership
- Private
- Employees
- ~2067
- Development stage
- Other
01
Overview
NYBC is a major US nonprofit providing blood, plasma, cord blood, and transfusion services to 600+ hospitals; it developed the first FDA-approved cord blood stem cell product (HEMACORD) and conducts research in cell therapy, blood group genomics, and infectious disease testing
- Therapeutic areas
- OncologyHematologyInfectious DiseasesImmunology
- Modalities
- Biologic (blood, plasma, cord blood, stem cells)Cell therapyRecombinant proteinSmall molecule
- Industry
- Biotech
02
Partnerships
University of California, Davis Health System (cord blood stem cell research)Mayo Clinic (convalescent plasma validation)Immucor (PreciseType HEA test)
Beyond the preview
Go deeper on New York Blood Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on New York Blood Health.